LAB Standard BioTools Inc. - Common Stock

NASDAQ · Life Sciences Tools & Services · 在 SEC EDGAR 上查看 ↗
$0.69
价格 · 八月 18, 2026
截至...的财报数据 八月 5, 2026

LAB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$0.69
市值
$282M
P/E (TTM)
-3.6
每股收益 (TTM)
$-0.20
营收 (TTM)
$85M
股息收益率
ROE
-17.6%
负债/权益
52周区间
$1 – $2

LAB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $85M
9-point trend, -16.3%
2017-12-31 2025-12-31
EPS $-0.20
7-point trend, +79.4%
2019-12-31 2025-12-31
自由现金流 $-83M
7-point trend, -222.0%
2017-12-31 2025-12-31
利润率 -87.8%
3-point trend, -8.6%
2018-12-31 2025-12-31

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
LAB
同行中位数
P/E (TTM)
5-point trend, -27.3%
-3.6
17.5
P/S (TTM) (市销率 (TTM))
5-point trend, +79.0%
3.3
3.3
P/B (市净率)
5-point trend, -63.8%
0.7
2.1
Price / FCF (股价/自由现金流)
5-point trend, +62.4%
-3.4

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
LAB
同行中位数
Gross Margin (毛利率)
3-point trend, -8.6%
49.9%
42.5%
Operating Margin (营业利润率)
5-point trend, -249.8%
-129.2%
Net Profit Margin (净利润率)
5-point trend, -128.7%
-87.8%
-56.5%
ROA
5-point trend, +29.5%
-12.7%
-17.2%
ROE
5-point trend, +51.6%
-17.6%
-41.3%
ROIC
5-point trend, +56.0%
-15.8%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
LAB
同行中位数
Current Ratio (流动比率)
5-point trend, +93.4%
4.2
4.9
Quick Ratio (速动比率)
5-point trend, -28.4%
1.2

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
LAB
同行中位数
Revenue YoY (营收同比增长)
5-point trend, -34.7%
-6.2%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, -34.7%
-4.5%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, -34.7%
-9.2%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
LAB
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +74.4%
$-0.20

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
LAB
同行中位数

LAB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 6 位分析师
  • 强烈买入 2 33.3%
  • 买入 2 33.3%
  • 持有 2 33.3%
  • 卖出 0 0.0%
  • 强烈卖出 0 0.0%

12个月价格目标

1 位分析师 · 2026-08-14
中位数目标 $1.35 +96.0%
平均目标 $1.35 +96.0%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
0.07%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $-0.03 $-0.01 -0.02%
2026年3月31日 $0.33 $-0.05 0.38%
2025年12月31日 $0.05 $-0.07 0.12%
2025年9月30日 $-0.09 $-0.06 -0.03%
2025年6月30日 $-0.09 $-0.08 -0.01%
2025年3月31日 $-0.07 $-0.08 0.01%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
LAB $495M -6.4 -6.2% -87.8% -17.6% 49.9%
MLAB $489M 73.1 3.4% 2.7% 3.7% 63.5%
OABI
DNA $484M -1.5 -25.1% -183.8% -55.8%
TKNO $204M -11.9 7.3% -42.6% -23.8% 33.2%
PACB $565M -1.0 3.9% -341.5% -1634.9% 28.6%
LFCR $249M -5.3 0.47% -30.0% -461.3% 31.3%
CDXS $147M -3.3 18.6% -62.5% -82.8%
QSI
MXCT $166M -3.7 -14.5% -135.1% -24.6% 81.2%
QTRX $297M -2.5 1.1% -77.1% -36.4% 46.8%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 18
LAB 的年度损益表数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue 12-point trend, -26.7% $85M $91M $106M $98M $131M $138M $117M $113M $102M $104M $115M $116M
Cost of Revenue 10-point trend, +14162.7% $43M $46M $56M $61M · · $53M $51M $50M $46M $43M $300.0K
Gross Profit 8-point trend, -27.2% $43M $45M $50M $37M · · $64M $62M $52M $58M · ·
R&D Expense 12-point trend, -40.2% $26M $29M $26M $37M $38M $36M $32M $30M $31M $38M $39M $43M
SG&A Expense 12-point trend, +54.0% $110M $103M $88M $102M $99M $98M $84M $80M $80M $93M $83M $71M
Operating Expenses 12-point trend, -9.2% $153M $172M $127M $153M $198M $189M $169M $161M $110M $132M $165M $168M
Operating Income 12-point trend, -112.7% $-110M $-127M $-77M $-116M $-67M $-51M $-52M $-48M $-58M $-73M $-50M $-52M
Interest Expense 10-point trend, -14.5% · · $5M $4M $4M $4M $4M $14M $6M $6M $6M $5M
Interest Income 4-point trend, +312.4% $9M $20M $6M $2M · · · · · · · ·
Other Non-op 12-point trend, +612.7% $4M $-5M $1M $-818.0K $482.0K $507.0K $1M $637.0K $385.0K $-1M $-1M $-857.0K
Pretax Income 12-point trend, -67.6% $-97M $-90M $-74M $-193M $-64M $-54M $-67M $-61M $-64M $-80M $-55M $-58M
Income Tax 12-point trend, -676.9% $-38M $542.0K $452.0K $-3M $-4M $-1M $-2M $-2M $-3M $-4M $-1M $-5M
Net Income 12-point trend, -41.8% $-75M $-139M $-75M $-190M $-59M $-53M $-65M $-59M $-61M $-76M $-53M $-53M
EPS (Basic) 7-point trend, +79.4% $-0.20 $-0.52 $-0.94 $-2.43 $-0.78 $-0.74 $-0.97 · · · · ·
EPS (Diluted) 7-point trend, +79.4% $-0.20 $-0.52 $-0.94 $-2.43 $-0.78 $-0.74 $-0.97 · · · · ·
Shares (Basic) 7-point trend, +471.5% 381,623,000 353,245,000 79,160,000 78,305,000 75,786,000 72,044,000 66,779,000 · · · · ·
Shares (Diluted) 7-point trend, +471.5% 381,623,000 353,245,000 79,160,000 78,305,000 75,786,000 72,044,000 66,779,000 · · · · ·
EBITDA 7-point trend, -98.2% $-101M $-163M · $-110M $-64M $-47M · $-43M $-51M · · ·
资产负债表 29
LAB 的年度资产负债表数据
指标 趋势 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +258.5% $121M $167M $52M $81M $28M $69M $22M $95M $58M $35M $29M $34M
Short-term Investments 9-point trend, +3.5% · · · $84M $0 $0 $37M $0 $5M $24M $66M $82M
Receivables 12-point trend, -40.0% $13M $15M $20M $17M $18M $25M $19M $17M $15M $15M $25M $22M
Inventory 12-point trend, +25.0% $20M $21M $21M $21M $21M $20M $14M $13M $15M $20M $18M $16M
Prepaid Expense 12-point trend, +119.3% $5M $5M $3M $4M $4M $4M $5M $2M $2M $3M $6M $2M
Current Assets 12-point trend, +191.4% $454M $376M $158M $209M $72M $118M $96M $127M $95M $97M $144M $156M
PP&E (Net) 12-point trend, +38.8% $19M $23M $24M $26M $28M $18M $8M $9M $12M $17M $15M $14M
PP&E (Gross) 12-point trend, +135.2% $67M $57M $57M $53M $50M $32M $33M $32M $34M $40M $34M $28M
Accum. Depreciation 12-point trend, +194.4% $48M $40M $35M $29M $27M $24M $25M $23M $22M $24M $20M $16M
Goodwill 11-point trend, +6.9% · $111M $106M $106M $106M $107M $104M $104M $104M $104M $104M $104M
Intangibles 11-point trend, -71.7% · $29M $1M $13M $28M $40M $46M $57M $69M $80M $91M $102M
Other Non-current Assets 12-point trend, -20.5% $3M $4M $2M $3M $4M $5M $5M $6M $8M $9M $9M $4M
Total Assets 12-point trend, +39.3% $568M $612M $323M $390M $275M $325M $265M $304M $287M $306M $370M $408M
Accounts Payable 12-point trend, -8.7% $5M $5M $9M $8M $11M $9M $5M $4M $4M $4M $6M $6M
Accrued Liabilities 12-point trend, +208.2% $30M $21M $21M $6M $9M $12M $9M $8M $8M $12M $11M $10M
Current Liabilities 12-point trend, +268.6% $108M $66M $109M $43M $50M $54M $33M $38M $33M $30M $30M $29M
Capital Leases 8-point trend, +25038000.00 $25M $26M $30M $34M $38M $38M $4M $0 · · · ·
Deferred Tax 12-point trend, -96.9% $810.0K $1M $841.0K $1M $4M $9M $11M $14M $17M $21M $24M $26M
Other Non-current Liabilities 12-point trend, -32.2% $1M $1M $1M $961.0K $882.0K $1M $573.0K $2M $6M $3M $2M $2M
Total Liabilities 12-point trend, -44.2% $143M $141M $160M $161M $181M $186M $111M $232M $256M $253M $255M $257M
Long-term Debt 4-point trend, -99.8% · $299.0K $64M $65M · · · · $195M · · ·
Common Stock 12-point trend, +1342.9% $404.0K $396.0K $83.0K $80.0K $77.0K $75.0K $70.0K $49.0K $39.0K $29.0K $29.0K $28.0K
Paid-in Capital 12-point trend, +275.5% $1.73B $1.70B $861M $847M $831M $816M $778M $632M $532M $493M $480M $461M
Retained Earnings 12-point trend, -306.4% $-1.26B $-1.19B $-1.00B $-926M $-736M $-677M $-624M $-559M $-500M $-439M $-363M $-310M
Treasury Stock 5-point trend, +46467000.00 $46M $46M $6M $563.0K $0 · · · · · · ·
AOCI 12-point trend, -87.9% $-1M $1M $-2M $-2M $-907.0K $112.0K $-582.0K $-687.0K $-574.0K $-760.0K $-1M $-794.0K
Stockholders' Equity 12-point trend, +182.1% $424M $472M $-148M $-81M $95M $139M $154M $72M $31M $53M $115M $150M
Liabilities + Equity 12-point trend, +39.3% $568M $612M $323M $390M $275M $325M $265M $304M $287M $306M $370M $408M
Shares Outstanding 12-point trend, +1263.3% 386,381,000 396,110,000 83,364,000 79,904,000 76,919,000 74,543,000 69,956,000 49,338,000 38,787,000 29,208,000 28,844,000 28,341,000
现金流 18
LAB 的年度现金流数据
指标 趋势 202520242023202220212020201920182017201620152014
D&A 12-point trend, +128.1% $9M $13M $4M $3M $3M $4M $5M $5M $7M $7M $5M $4M
Stock-based Comp 12-point trend, +41.4% $30M $32M $13M $15M $16M $14M $11M $11M $9M $14M $17M $21M
Deferred Tax 12-point trend, -652.9% $-39M $206.0K $-118.0K $-3M $-4M $-3M $-3M $-2M $-4M $-4M $-3M $-5M
Amort. of Intangibles 12-point trend, -82.5% $2M $4M $11M $12M $12M $12M $11M $11M $11M $11M $11M $10M
Restructuring 4-point trend, +51.9% $15M $12M $7M $10M · · · · · · · ·
Other Non-cash 7-point trend, -98.1% $446.0K $-49M · $83M $-259.0K $23M · $20M $24M · · ·
Operating Cash Flow 12-point trend, -228.6% $-74M $-143M $-43M $-89M $-44M $-15M $-35M $-25M $-24M $-39M $-35M $-23M
CapEx 12-point trend, +12.2% $8M $8M $3M $4M $13M $13M $3M $372.0K $2M $5M $4M $7M
Investing Cash Flow 12-point trend, +115.4% $27M $363M $20M $-88M $-12M $40M $-39M $5M $18M $45M $26M $-178M
Net Debt Issued 3-point trend, +0.00 · · · $0 $-501.0K $0 · · · · · ·
Stock Issued 7-point trend, +0.00 · · · · $0 $20M $0 $59M $29M $0 $0 ·
Stock Repurchased 5-point trend, +0.00 $0 $40M $5M $563.0K $0 · · · · · · ·
Net Stock Activity 7-point trend, -100.0% $0 $-40M · $-563.0K $0 $20M · $59M $29M · · ·
Financing Cash Flow 12-point trend, -99.7% $570.0K $-103M $-7M $231M $16M $21M $3M $58M $29M $116.0K $5M $200M
Net Change in Cash 12-point trend, -2840.7% $-46M $116M $-30M $53M $-40M $46M $-72M $37M $23M $6M $-5M $-2M
Taxes Paid 10-point trend, -120.6% $-73.0K $607.0K $801.0K $309.0K $2M $521.0K $205.0K $321.0K $245.0K $355.0K · ·
Free Cash Flow 7-point trend, -222.0% $-83M $-152M · $-93M $-57M $-28M · $-26M $-26M · · ·
Levered FCF 5-point trend, -212.5% · · · $-97M $-61M $-32M · $-39M $-31M · · ·
盈利能力 8
LAB 的年度盈利能力数据
指标 趋势 202520242023202220212020201920182017201620152014
Gross Margin 3-point trend, -8.6% 49.9% 48.3% · · · · · 54.6% · · · ·
Operating Margin 7-point trend, -125.7% -129.2% -100.5% · -118.6% -51.7% -36.9% · -42.6% -57.2% · · ·
Net Margin 7-point trend, -47.8% -87.8% -79.6% · -194.1% -45.4% -38.4% · -52.2% -59.4% · · ·
Pretax Margin 7-point trend, -81.1% -113.3% -79.3% · -197.0% -48.8% -39.2% · -54.4% -62.6% · · ·
EBITDA Margin 7-point trend, -136.8% -118.3% -93.3% · -112.3% -48.9% -34.0% · -37.9% -50.0% · · ·
ROA 7-point trend, +37.8% -12.7% -29.7% · -57.1% -19.8% -18.0% · -20.0% -20.4% · · ·
ROE 7-point trend, +87.7% -17.6% -28.9% · 263.6% -61.1% -36.4% · -124.9% -143.8% · · ·
ROIC 7-point trend, +91.2% -15.8% -37.3% · 140.6% -66.4% -36.0% · -64.2% -179.0% · · ·
流动性与偿付能力 3
LAB 的年度流动性与偿付能力数据
指标 趋势 202520242023202220212020201920182017201620152014
Current Ratio 7-point trend, +48.1% 4.2 5.7 · 4.8 1.5 2.2 · 3.4 2.8 · · ·
Quick Ratio 7-point trend, -46.9% 1.2 3.0 · 4.2 0.9 1.7 · 3.0 2.3 · · ·
Interest Coverage 5-point trend, -167.8% · · · -26.8 -17.6 -14.3 · -3.5 -10.0 · · ·
效率 3
LAB 的年度效率数据
指标 趋势 202520242023202220212020201920182017201620152014
Asset Turnover 7-point trend, -57.9% 0.1 0.4 · 0.3 0.4 0.5 · 0.4 0.3 · · ·
Inventory Turnover 4-point trend, -17.9% 2.1 2.9 · · · · · 3.7 2.6 · · ·
Receivables Turnover 7-point trend, -11.9% 6.1 6.5 · 5.5 6.0 6.2 · 7.1 6.9 · · ·
每股 5
LAB 的年度每股数据
指标 趋势 202520242023202220212020201920182017201620152014
Book Value / Share 7-point trend, +37.7% $1.10 $1.25 · $-1.02 $1.23 $1.87 · $1.46 $0.80 · · ·
Revenue / Share 4-point trend, -87.0% $0.22 $0.49 · $1.25 $1.72 · · · · · · ·
Cash Flow / Share 4-point trend, +66.5% $-0.19 $-0.41 · $-1.14 $-0.58 · · · · · · ·
Cash / Share 7-point trend, -79.1% $0.31 $0.44 · $1.02 $0.37 $0.92 · $1.93 $1.50 · · ·
EPS (TTM) 7-point trend, +79.4% $-0.20 $-0.52 $-0.94 $-2.43 $-0.78 $-0.74 $-0.97 · · · · ·
增长率 3
LAB 的年度增长率数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -14.1% -6.2% -14.4% 8.6% -25.0% -5.5% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +46.2% -4.5% -11.3% -8.3% · · · · · · · · ·
Revenue CAGR 5Y -9.2% · · · · · · · · · · ·
估值 (TTM) 10
LAB 的年度估值 (TTM)数据
指标 趋势 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -26.7% $85M $91M $106M $98M $131M $138M $117M $113M $102M $104M $115M $116M
Net Income TTM 12-point trend, -41.8% $-75M $-139M $-75M $-190M $-59M $-53M $-65M $-59M $-61M $-76M $-53M $-53M
Market Cap 7-point trend, +116.5% $495M $661M · $93M $302M $447M · $425M $228M · · ·
P/E 7-point trend, -78.4% -6.4 -3.4 -2.4 -0.5 -5.0 -8.1 -3.6 · · · · ·
P/S 7-point trend, +158.6% 5.8 7.3 · 0.9 2.3 3.2 · 3.8 2.2 · · ·
P/B 7-point trend, -84.2% 1.2 1.4 · -1.1 3.2 3.2 · 5.9 7.4 · · ·
P / Tangible Book 2-point trend, -41.5% 1.2 2.0 · · · · · · · · · ·
P / Cash Flow 7-point trend, +29.8% -6.7 -4.6 · -1.0 -6.8 -29.0 · -16.9 -9.5 · · ·
P / FCF 7-point trend, +32.8% -6.0 -4.4 · -1.0 -5.3 -15.9 · -16.6 -8.9 · · ·
Earnings Yield 7-point trend, +43.9% -15.6% -29.7% -42.5% -207.7% -19.9% -12.3% -27.9% · · · · ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $85M$91M$106M$98M$131M
毛利率 % 49.9%48.3%
营业利润率 % -129.2%-100.5%-118.6%-51.7%
净收入 $-75M$-139M$-75M$-190M$-59M
稀释后每股收益 (EPS) $-0.20$-0.52$-0.94$-2.43$-0.78
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
流动比率 4.25.74.81.5
速动比率 1.23.04.20.9
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $-83M$-152M$-93M$-57M

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 165 家申报者 · $232.0M 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
48 (+26 与上一季度对比) 47 (+23 与上一季度对比) 48 (+4 与上一季度对比) 33 (-14 与上一季度对比) +34.8M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
Casdin Capital, LLC $73042478 88783856 31.48% 股份
VIKING GLOBAL INVESTORS LP $48252318 58651170 20.80% 股份
MAK CAPITAL ONE LLC $23705199 28813904 10.22% 股份
Long Focus Capital Management, LLC $19333450 23500000 8.33% 股份
VANGUARD CAPITAL MANAGEMENT LLC $10084217 12252998 4.35% 股份
Hollow Brook Wealth Management LLC $4527632 5503381 1.95% 股份
Qube Research & Technologies Ltd $3965795 4820463 1.71% 股份
NEUBERGER BERMAN GROUP LLC $3901326 4791027 1.68% 股份
ROYCE & ASSOCIATES LP $3722991 4525333 1.60% 股份
Tikvah Management LLC $2921455 3551058 1.26% 股份
MILLENNIUM MANAGEMENT LLC $2889869 3512665 1.25% 股份
GEODE CAPITAL MANAGEMENT, LLC $2641142 3208334 1.14% 股份
VANGUARD GROUP INC $2463716 1924778 1.06% 股份
Peapod Lane Capital LLC $1983920 2411474 0.86% 股份
CITADEL ADVISORS LLC $1932169 2348570 0.83% 股份
Mink Brook Asset Management LLC $1802513 2190973 0.78% 股份
Sone Capital Management, LLC $1755338 2133631 0.76% 股份
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $1638346 1991426 0.71% 股份
VANGUARD FIDUCIARY TRUST CO $1555343 1889846 0.67% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $1447161 1759038 0.62% 股份
Price Jennifer C. $1405744 803282 0.61% 股份
D. E. Shaw & Co., Inc. $1397776 1699011 0.60% 股份
JACOBS LEVY EQUITY MANAGEMENT, INC $1343561 1633112 0.58% 股份
STATE STREET CORP $1268997 1542478 0.55% 股份
Loews Corp $1028375 1250000 0.44% 股份
RENAISSANCE TECHNOLOGIES LLC $816166 992058 0.35% 股份
STALEY CAPITAL ADVISERS INC $658160 800000 0.28% 股份
Man Group plc $611096 742793 0.26% 股份
Point72 Asset Management, L.P. $582464 707991 0.25% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $555305 674733 0.24% 股份
JANE STREET GROUP, LLC $445416 541408 0.19% 股份
Aster Capital Management (DIFC) Ltd $445188 541130 0.19% 股份
Jain Global LLC $384462 467317 0.17% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $357295 434296 0.15% 股份
Sumitomo Mitsui Trust Group, Inc. $339189 412288 0.15% 股份
Amova Asset Management Americas, Inc. $338076 412288 0.15% 股份
Intellectus Partners, LLC $332948 404702 0.14% 股份
HighTower Advisors, LLC $292537 355581 0.13% 股份
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $270301 328553 0.12% 股份
OPPENHEIMER & CO INC $268694 326600 0.12% 股份
Marquette Asset Management, LLC $267662 325345 0.12% 股份
JOHNSON & JOHNSON $256655 311967 0.11% 股份
Susquehanna Portfolio Strategies, LLC $239828 291513 0.10% 股份
XTX Topco Ltd $228567 277826 0.10% 股份
Squarepoint Ops LLC $228196 277375 0.10% 股份
HSBC HOLDINGS PLC $218766 271523 0.09% 股份
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $216884 235923 0.09% 股份
Y-Intercept (Hong Kong) Ltd $216595 263273 0.09% 股份
Brevan Howard Capital Management LP $199357 242320 0.09% 股份
BANK OF AMERICA CORP /DE/ $189063 230004 0.08% 股份
QVIDTVM Management LLC $182639 222000 0.08% 股份
Invesco Ltd. $182562 221906 0.08% 股份
IEQ CAPITAL, LLC $164428 199864 0.07% 股份
PRIMECAP MANAGEMENT CO/CA/ $126181 153374 0.05% 股份
JANUS HENDERSON GROUP PLC $121384 131610 0.05% 股份
Abich Financial Wealth Management LLC $118882 91448 0.05% 股份
BlackRock, Inc. $113314 137734 0.05% 股份
Vanguard Global Advisers, LLC $106433 129323 0.05% 股份
Schonfeld Strategic Advisors LLC $97604 118639 0.04% 股份
Catalyst Funds Management Pty Ltd $91151 110795 0.04% 股份
MERCER GLOBAL ADVISORS INC /ADV $83406 101381 0.04% 股份
RHUMBLINE ADVISERS $80965 98378 0.03% 股份
AMERIPRISE FINANCIAL INC $79646 96810 0.03% 股份
Mariner, LLC $75279 91537 0.03% 股份
Bank of New York Mellon Corp $74273 90280 0.03% 股份
State of Wyoming $61924 75269 0.03% 股份
BOOTHBAY FUND MANAGEMENT, LLC $58214 70760 0.03% 股份
Nuveen Asset Management, LLC $57554 32888 0.02% 股份
Engineers Gate Manager LP $56491 68665 0.02% 股份
Hudson Bay Capital Management LP $52686 64040 0.02% 股份
NORTHERN TRUST CORP $51653 62785 0.02% 股份
PRUDENTIAL FINANCIAL INC $49626 60321 0.02% 股份
CWM, LLC $48860 53149 0.02% 股份
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $47297 51466 0.02% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $45920 56000 0.02% 卖出期权
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $41909 51900 0.02% 股份
Evercore Wealth Management, LLC $41135 50000 0.02% 股份
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $38655 42090 0.02% 股份
Focus Partners Wealth $38309 46565 0.02% 股份
VICTORY CAPITAL MANAGEMENT INC $35709 43405 0.02% 股份
Balyasny Asset Management L.P. $31703 38535 0.01% 股份
GOLDMAN SACHS GROUP INC $29183 35472 0.01% 股份
CIBC WORLD MARKETS CORP $25348 19803 0.01% 股份
Atom Investors LP $24332 29576 0.01% 股份
CAPTRUST FINANCIAL ADVISORS $23646 28742 0.01% 股份
BARCLAYS PLC $22686 27574 0.01% 股份
ExodusPoint Capital Management, LP $22103 26867 0.01% 股份
UBS Group AG $21491 26113 0.01% 股份
TAKEDA PHARMACEUTICAL CO LTD $21470 16515 0.01% 股份
Platform Technology Partners $20568 25000 0.01% 股份
EverSource Wealth Advisors, LLC $19834 24108 0.01% 股份
SEI INVESTMENTS CO $19760 24039 0.01% 股份
CITIGROUP INC $19253 23402 0.01% 股份
BRIGHTON JONES LLC $18054 21944 0.01% 股份
WOLVERINE TRADING, LLC $18034 14200 0.01% 买入期权
Laurion Capital Management LP $17952 21821 0.01% 股份
Cerity Partners LLC $17272 20995 0.01% 股份
Connor, Clark & Lunn Investment Management Ltd. $17120 20809 0.01% 股份
Creative Planning $15209 18487 0.01% 股份
Jefferies Financial Group Inc. $14541 17675 0.01% 股份

公司内部人士 38 位内幕人士 · 17 位高管 · 19 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Michael Egholm President & CEO 2026年8月3日 F 6235331 0 0 $0
Stephen Christopher Linthwaite President & CEO 2022年2月22日 M 328473 0 0 $0
Hanjoon Alex Kim Chief Financial Officer 2026年7月23日 F 2563054 0 0 $0
Jeffrey G. Black SVP & Chief Financial Officer 2024年8月20日 F 421608 0 0 $0
Vikram Jog Chief Financial Officer 2023年2月21日 A 217622 0 0 $0
Fredric T Walder CHIEF OPERATING OFFICER 2015年8月20日 M 2915 0 0 $0
Sean Mackay SVP & Chief Business Officer 2026年6月20日 A 1506552 0 0 $0
Jeremy Steven Davis SVP Chief Commercial Officer 2023年2月21日 M 14657 0 0 $0
Nicholas Khadder SVP, Gen. Counsel & Secretary 2022年5月31日 A 100480 0 0 $0
Bradley Allen Kreger SVP, Global Operations 2022年5月20日 M 119157 0 0 $0
Colin Mccracken Chief Commercial Officer 2022年2月22日 M 65103 0 0 $0
Steven Mcphail Chief Commercial Officer 2019年4月18日 F 78203 0 0 $0
Jennifer Ling Lee Vice President, Controller, and Principal Accounting Officer 2018年2月20日 M 6716 0 0 $0
Mai Chan Yow Executive Vice President, Worldwide Manufacturing of Fluidigm Singapore Pte. Ltd. 2017年9月20日 A 19705 0 0 $0
Marc Unger EVP, R&D and Marketing 2016年8月22日 M 6413 0 0 $0
Robert C Jones Chief Technology Officer, Genomics 2016年8月22日 M 3897 0 0 $0
William Maxwell Smith EVP, LEGAL AFFAIRS, SECRETARY & GC 2016年3月4日 A 2563 0 0 $0
Troy Cox 董事 2026年6月18日 A 475702 0 0 $0
Thomas D. Carey 董事 2026年6月18日 A 344456 0 0 $0
Eli Casdin 董事 2026年6月18日 A 3053169 0 0 $0
Frank Witney 董事 2026年6月18日 A 309978 0 0 $0
Kathy L Hibbs 董事 2026年6月18日 A 236836 0 0 $0
Fenel M Eloi 董事 2026年6月18日 A 335299 0 0 $0
Martin D Madaus 董事 2023年10月20日 A 104111 0 0 $0
Carlos V Paya 董事 2023年6月14日 A 126844 0 0 $0
Laura Clague 董事 2023年6月14日 A 104791 0 0 $0
Bill Colston 董事 2022年6月15日 A 59288 0 0 $0
Gerhard F Burbach 董事 2022年6月15日 A 96827 0 0 $0
Nicolas Barthelemy 董事 2022年4月1日 M 204077 0 0 $0
Ana K. Stankovic 董事 2021年5月25日 A 18563 0 0 $0
Samuel D Colella 董事 2020年3月11日 P 161109 0 0 $0
Patrick S Jones 董事 2019年6月3日 A 23087 0 0 $0
John A Young 董事 2017年7月31日 M 5849 0 0 $0
Kenneth J Nussbacher 董事 2011年8月29日 J 169 0 0 $0
Raymond J Whitaker 董事 2011年2月15日 C 868908 0 0 $0
Caligan Partners LP 10% 所有者 2022年12月29日 J 8576799 0 0 $0
Evan/ Fa Jones 2017年7月31日 M 58551 0 0 $0
Gajus Vincent Worthington 2016年10月19日 D 13538 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 6 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
VIKING GLOBAL INVESTORS LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global Opportunities Drawdown GP LLC, Viking Global Opportunities Drawdown Portfolio GP LLC, Viking Global Opportunities Drawdown (Aggregator) LP, HALVORSEN OLE ANDREAS, Shabet Rose Sharon ×3 申报 2026年6月12日 15.00% 初始申报 并购/出售 SEC
Casdin Capital, LLC, Casdin Private Growth Equity Fund II, L.P., Casdin Private Growth Equity Fund II GP, LLC, Casdin Partners Master Fund, L.P., Casdin Partners GP, LLC, Eli Casdin ×9 申报 2026年6月9日 23.90% 修订 并购/出售 SEC
未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人, 未披露的报告人 2024年1月12日 初始申报 SEC
Caligan Partners LP, David Johnson ×8 申报 2024年1月8日 初始申报 SEC
Neuberger Berman Group LLC, Neuberger Berman Investment Advisers Holdings LLC, Neuberger Berman Investment Advisers LLC, Neuberger Berman Canada Holdings LLC, NB Acquisitionco ULC, Neuberger Berman Canada ULC, Benjamin Nahum, Amit Solomon, Rand Gesing, Pong Chan 2021年11月18日 初始申报 SEC
Levin Capital Strategies, L.P., Levin Capital Strategies GP, LLC, Bi-Directional Disequilibrium Fund, L.P., LCS, LLC, John A. Levin ×9 申报 2019年4月2日 初始申报 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 17 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
GNOM · Global X Funds 0.35% 170786 NS 2026年5月31日 N-PORT
QQQS · Invesco Exchange-Traded Fund Trus... 0.34% 97237 SH 2026年8月8日 每日
IBB · iShares Trust 0.02% 2737497 SH 2026年8月8日 每日
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.02% 141511 NS 2026年5月31日 N-PORT
ITWO · ProShares Trust 0.01% 13531 NS 2026年5月31日 N-PORT
RSSL · Global X Funds 0.01% 124578 NS 2026年4月30日 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.01% 1428280 NS 2026年5月31日 N-PORT
UWM · ProShares Trust 0.00% 10582 NS 2026年5月31日 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.00% 118488 NS 2026年4月30日 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.00% 129815 SH 2026年8月8日 每日
URTY · ProShares Trust 0.00% 10704 NS 2026年5月31日 N-PORT
HDG · ProShares Trust 0.00% 269 NS 2026年5月31日 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0.00% 181462 NS 2026年5月31日 N-PORT
ITOT · iShares Trust 0.00% 336441 SH 2026年8月8日 每日
VXF · VANGUARD INDEX FUNDS 0.00% 3520649 SH 2026年8月8日 每日
VTI · VANGUARD INDEX FUNDS 0.00% 8433842 SH 2026年8月8日 每日
VHT · VANGUARD WORLD FUND 0.00% 674733 SH 2026年8月8日 每日